Insulin Dosing Practices in Persons With Diabetes on Multiple Daily Injections
NCT02914730 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75
Last updated 2018-08-14
Summary
In this cross-sectional study the investigators will examine two populations: young adults with (ages 18-35) and older adults (ages 65 and over) with diabetes who are on \> 2 insulin injections per day. The sample size for this observational study will be up to 125 patients. The investigators will issue a Common Sensing GoCap bluetooth-enabled pen cap that fits on the end of Solostar Lantus and Apidra insulin pens; this pen cap registers the position of the insulin pen plunger and automatically sends confirmation of dose delivery to a smartphone app.
Conditions
- Diabetes
- Medication Adherence
- Technology
- Insulin
Sponsors & Collaborators
-
Joslin Diabetes Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-09-30
- Primary Completion
- 2018-07-31
- Completion
- 2018-07-31
Countries
- United States
Study Locations
More Related Trials
-
A Study to Assess the Effect of Smart Insulin Pens on Glycemic Control and Diabetes-related Burdens
NCT05036343 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Use of a Graded Infusion of Intravenous Glucose in the Assessment of Insulin Secretion Rates (MK-0000-078)
NCT01021462 ·Status: COMPLETED ·Phase: PHASE1
-
Insulin Pump Therapy in Adolescents With Newly Diagnosed Type 1 Diabetes (T1D)
NCT00357890 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effects of Heating the Vicinity of the Insulin Delivery Site by the InsuPatch Device During Daily Life
NCT01114061 ·Status: SUSPENDED ·Phase: NA
-
A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes
NCT07305805 ·Status: RECRUITING ·Phase: PHASE1
-
Evaluation of a Decision Support System for People With Diabetes Who Use Multiple Daily Insulin Injections- Feasibility and Proof of Concept Studies
NCT04653961 ·Status: RECRUITING ·Phase: NA
-
Insulin Dosage Software Program for People With Type 1 and Type 2 Diabetes
NCT01170208 ·Status: COMPLETED ·Phase: NA
-
A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump
NCT00115973 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Evaluation of a Dose Guidance System for People With Diabetes Initiating Basal Insulin or Using Insulin Injections
NCT06966427 ·Status: RECRUITING ·Phase: NA
-
Insulin Degludec Titration Using Mobile Insulin Dosing System
NCT03091712 ·Status: COMPLETED ·Phase: NA
-
Patient and Parent Preferences for an On-Body Automated Insulin Delivery System
NCT03534544 ·Status: COMPLETED
-
Assessment of Mealtime Bolus Insulin Behavior
NCT03368807 ·Status: COMPLETED
-
OP5-005 Using Omnipod 5 in Adults With Type 2
NCT05815342 ·Status: COMPLETED ·Phase: NA
-
A Study Evaluating the Perception of Insertion Pain With Accu-Chek FlexLink and FlexLink Plus Insulin Pump Devices Under Real Life Conditions in Diabetic Patients.
NCT02103595 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes Mellitus on Multiple Daily Injections (MDI) or Continuous Subcutaneous Insulin Infusion (CSII) Therapy
NCT01104142 ·Status: COMPLETED
-
A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps
NCT02703324 ·Status: COMPLETED ·Phase: PHASE1
-
Syringes Replacement for Insulin Application for Pens Device in a Population of Elderly Patients With Type 2 Diabetes: Multifactorial Intervention to Improve Glycemic Control
NCT02517242 ·Status: UNKNOWN ·Phase: PHASE4
-
A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition
NCT00287066 ·Status: TERMINATED ·Phase: PHASE3
-
Continuous Glucose Sensing at the Site of Subcutaneous Insulin Administration
NCT02359617 ·Status: COMPLETED ·Phase: NA
-
Real-time Adaptation to Changes in Insulin Sensitivity
NCT01261052 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effect of the InsuPatch Device on Insulin Pharmacokinetics in Clamp Studies
NCT01216618 ·Status: COMPLETED ·Phase: PHASE3
-
Observational, Data Collection Study for Subjects With Diabetes Using Insulin Injections
NCT04013919 ·Status: UNKNOWN
-
A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump
NCT03056456 ·Status: COMPLETED ·Phase: PHASE1
-
Intra-Arterial Microdosing: Proof-of-Concept in Humans
NCT02304211 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Crossover Study Assessing the Pharmacokinetics, Pharmacodynamics, and Safety of Recombinant Human Insulin
NCT00358553 ·Status: COMPLETED ·Phase: PHASE1